Growth equity firm Foresite Capital is looking to invest its newly-raised $300 million in late-stage healthcare companies with a "revolutionary" edge.
Healthcare investment firm Foresite Capital has a new $300 million pool to spend on late-stage healthcare firms, and the company is looking for "transformative" innovations.
Coming off of a $100 million fundraiser just earlier this year, Foresite closed its latest round with an over-subscription of capital commitments for healthcare investment.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1k7utZK
Cap comentari:
Publica un comentari a l'entrada